Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc (PLRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Loss, Misses Revenue Estimates

Pliant Therapeutics, Inc. (PLRX) delivered earnings and revenue surprises of 12.16% and 34.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

PLRX : 19.52 (+0.31%)
SPRO : 1.9300 (+1.05%)
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of 16.67% and 9.74%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CDXS : 5.03 (-0.20%)
PLRX : 19.52 (+0.31%)
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year?

Here is how Assertio (ASRT) and Pliant Therapeutics, Inc. (PLRX) have performed compared to their sector so far this year.

ASRT : 2.94 (+2.44%)
PLRX : 19.52 (+0.31%)
3 Soaring Biotech Stocks That Could Climb Much Higher

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

BLTE : 32.98 (+3.73%)
CINC : 12.50 (-11.41%)
PLRX : 19.52 (+0.31%)
AVEO Pharmaceuticals (AVEO) Inks Deal to be Acquired by LG Chem

Aveo Pharmaceuticals (AVEO) is set to be acquired by LG Chem for an aggregate amount of $566 billion. The deal is expected to close by early 2023. Stock up.

BMRN : 97.12 (-1.56%)
AVEO : 14.87 (+0.07%)
ACAD : 14.67 (-0.68%)
PLRX : 19.52 (+0.31%)
Milestone's (MIST) Tachycardia Study Data Fail to Impress Investors

Milestone (MIST) reports positive top-line results from its late-stage study evaluating its lead candidate, etripamil, in patients with paroxysmal supraventricular tachycardia. The results fail to impress...

BMRN : 97.12 (-1.56%)
ACAD : 14.67 (-0.68%)
MIST : 4.92 (-1.80%)
PLRX : 19.52 (+0.31%)
Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.

MRK : 108.84 (+0.36%)
EBS : 11.77 (+1.38%)
INO : 1.9300 (+1.58%)
PLRX : 19.52 (+0.31%)
Axsome (AXSM) up 118.4% in the Past Three Months: Here's Why

Axsome (AXSM) surges in the past three months owing to its Sunosi acquisition and promising progress on its pipeline candidate.

JAZZ : 155.65 (+1.10%)
AXSM : 70.84 (-5.22%)
SESN : 0.5600 (+4.67%)
PLRX : 19.52 (+0.31%)
Has Pliant Therapeutics (PLRX) Outpaced Other Medical Stocks This Year?

Here is how Pliant Therapeutics, Inc. (PLRX) and Alaunos (TCRT) have performed compared to their sector so far this year.

PLRX : 19.52 (+0.31%)
TCRT : 0.6734 (-22.78%)
Pliant Therapeutics, Inc. (PLRX) Upgraded to Buy: What Does It Mean for the Stock?

Pliant Therapeutics, Inc. (PLRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PLRX : 19.52 (+0.31%)

Barchart Exclusives

Buy This Call Option to Ride Hain Celestial’s Good News
Organic and natural foods producer Hain Celestial Group appointed a new CEO on Monday. Here’s how options investors should play this good news. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar